Home Newsfeeds Barclays Maintains Overweight on Veeco Instruments, Lowers Price Target to $24

Barclays Maintains Overweight on Veeco Instruments, Lowers Price Target to $24

Barclays analyst Tom O'Malley maintains Veeco Instruments (NASDAQ:VECO) with a Overweight and lowers the price target from $26 to $24.

byBenzinga Newsdesk

September 28, 2022

1 minute read

Barclays analyst Tom O’Malley maintains Veeco Instruments (NASDAQ:VECO) with a Overweight and lowers the price target from $26 to $24.

Here’s How Much You Would Have Made Owning Corning Stock In The Last 20 Years

By Benzinga Insights

November 25, 11:34 AM

Corning (NYSE:GLW) has outperformed the market over the past 20 years by 3.07% on an annualized basis producing…

GLW

Analyst Ratings

What Analysts Are Saying About Cerence Stock

By Benzinga Insights

May 10, 1:00 PM

Ratings for Cerence (NASDAQ:CRNC) were provided by 6 analysts in the past three months, showcasing a mix of…

CRNC

Billionaire Investor Gundlach Foresees Recession, Recommends Cash Over Overvalued Stocks: ‘Skip This Last Phase Of The Exuberance Game’

By Rounak Jain

January 27, 3:09 AM

Billionaire investor Jeffrey Gundlach sounded a note of caution, saying despite the "exuberance" in equity markets, a recession seems to be "inevitable."

NVDA

Why Is Research Company Exponent Stock Soaring Today?

By Shivani Kumaresan

April 26, 12:16 PM

Exponent soars on impressive Q1 FY24 results, with sales surging 3.3% YoY to $144.933M, outperforming estimates. Engineering and scientific services dominate revenue, comprising 84% of Q1 earnings, showcasing robust growth.

EXPO

Barclays Maintains Overweight on Veeco Instruments, Lowers Price Target to $24

Related Posts

Here’s How Much You Would Have Made Owning Corning Stock In The Last 20 Years

What Analysts Are Saying About Cerence Stock

Billionaire Investor Gundlach Foresees Recession, Recommends Cash Over Overvalued Stocks: ‘Skip This Last Phase Of The Exuberance Game’

Why Is Research Company Exponent Stock Soaring Today?